Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2005
03/30/2005EP1517724A2 Anti-angiogenic proteins and fragmentsand methods of use thereof
03/30/2005EP1517710A1 Pegylated factor vii glycoforms
03/30/2005EP1517702A2 IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE
03/30/2005EP1517701A2 Lewis y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/30/2005EP1517700A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/30/2005EP1517605A2 Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof
03/30/2005EP1517604A2 No-apical meristem proteins, polynucleotides and methods of use for same
03/30/2005EP1446496A4 Methods for ligand discovery
03/30/2005EP1429648A4 METHODS FOR SCREENING FOR SUBSTANCES WHICH INHIBIT FP PROSTANOID RECEPTOR INTERACTION WITH A COMPOUND HAVING PGF 2$g(a)alpha?ACTIVITY AND METHODS OF TREATING CANCER
03/30/2005EP1392341B1 Pharmaceutical composition containing a stabilised mrna which is optimised for translation in the coding regions thereof
03/30/2005EP1390501A4 Determination of a genetic predisposition for behavioural disorders
03/30/2005EP1311697B1 Constitutive promoter from arabidopsis
03/30/2005EP1229781A4 Seed trait genes
03/30/2005EP1229780A4 Yield-related genes
03/30/2005EP1200105B1 Modified factor viii
03/30/2005EP1187925B1 Pectate lyase fusion for expression and secretion of polypeptides
03/30/2005EP1185294B1 Peptides for the treatment of impaired interpersonal and behavioral disorders
03/30/2005EP1183361B1 Gene therapy of pulmonary disease
03/30/2005EP1135414B1 Allo and auto-reactive t-cell epitopes
03/30/2005EP1124570A4 Novel neuropilin/growth factor binding and uses thereof
03/30/2005EP1080187A4 Modification of cereal grain hardness via expression of puroindoline proteins
03/30/2005EP1047777B1 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
03/30/2005EP1019532B1 Primers and probes for the amplification, detection and typing of mycoplasma pneumoniae
03/30/2005EP1001978B1 Angiotensin derivatives
03/30/2005EP0876610A4 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility
03/30/2005EP0838474B1 Peptide that inhibits blood triglyceride level rise and blood triglyceride level rise inhibitor containing said peptide as active ingredient
03/30/2005EP0585415B1 Dna encoding a human 5-ht 1e receptor and uses thereof
03/30/2005EP0542830B1 Assay methods and compositions for detecting and evaluating the intracellular transduction of an extracellular signal
03/30/2005CN1602426A Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
03/30/2005CN1602360A Methods of increasing endogenous erythropoietin (EPO)
03/30/2005CN1602358A Recombinant fusion proteins and the trimers thereof
03/30/2005CN1602356A Transgenic organism expressing fungal MRP-like ABC transporters
03/30/2005CN1602355A Human fibroblast growth factor-related compositions
03/30/2005CN1602354A Human coagulation factor VII polypeptides
03/30/2005CN1602352A Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof
03/30/2005CN1602316A Flavivirus NS1 subunit vaccine
03/30/2005CN1602207A Methods for inhibiting ocular processes
03/30/2005CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/30/2005CN1602202A A method for identification and development of therapeutic agents
03/30/2005CN1602201A Peptides and related compounds having thrombopoietic activity
03/30/2005CN1600861A Protein coded sequence of binding factor in ethane response element of cotton
03/30/2005CN1600860A Meiosis gene of paddy, coding protein and application
03/30/2005CN1600857A RIP5 gene and usage
03/30/2005CN1600852A Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup B
03/30/2005CN1600792A Active material of polypeptide proteins in bloody clam, preparation method and usage
03/30/2005CN1600791A SARS antigen peptide
03/30/2005CN1600789A Promotive factor for activating NF-kappa B and usage
03/30/2005CN1600788A Distinguishing gene for adjusting and controlling anti-oncogene p53 and usage
03/30/2005CN1195063C Proteinase inhibitor fusion proteins
03/30/2005CN1195056C Recombined virus for specific proliferation and high efficiency expression of anti-cancer gene in tumor cells and its constitution method
03/30/2005CN1194990C Polypeptide motif bound with human CD95 and its polypeptide
03/30/2005CN1194989C Novel human protein able to suppress cancer cell growth and its coding sequence
03/30/2005CN1194988C Killer cell antibiosis polypeptide activated lymphokine and its application
03/30/2005CN1194987C Purified polypeptide with bioactiveity and medicine preparied from it for promoting growth and and development of animal's nerve cells and suppressing their apotosis
03/29/2005US6872871 Mapping molecular interactions in plants with protein fragments complementation assays
03/29/2005US6872869 Method for establishing an expression system of spider dragline silk gene in bombyx mori
03/29/2005US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof
03/29/2005US6872812 Hepp, a novel gene with a role in hematopoietic and neural development
03/29/2005US6872811 HRPCa9 and HRPCa10 nucleic acids and polypeptides
03/29/2005US6872808 Nematode-extracted serine protease inhibitors and anticoagulant proteins
03/29/2005US6872806 Polypeptide compositions formed using a coiled-coil template and methods of use
03/29/2005US6872803 Acyclic peptide having a particular structure is bonded to a physiologically active peptide; the peptides have higher stability and/or higher activity than physiologically active linear peptides to which no cyclic peptide is bonded
03/29/2005US6872704 Genes that are differentially-regulated during feeding and fasting cycles; useful to combat obesity and other metabolic disorders
03/29/2005US6872703 Insulin receptor-related receptor binding protein
03/29/2005US6872702 Cyclic peptide; antitumor agents; antiinflammatory agents; tissue remodeling
03/29/2005US6872700 Methods for glucagon suppression
03/29/2005US6872699 Truncated Flk-1 receptor protein, methods of use and a recombinant vector containing a nucleotide encoding the truncated Flk-1 protein
03/29/2005US6872574 Proteomic analysis
03/29/2005US6872568 Death domain containing receptor 5 antibodies
03/29/2005US6872559 Diagnosis of urogenital disorders
03/29/2005US6872551 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
03/29/2005US6872550 Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
03/29/2005US6872548 Polypeptide for use in animal models associated with human therapeutics
03/29/2005US6872547 Functional balanced-lethal host-vector systems
03/29/2005US6872546 Hyaluronan-binding proteins and encoding genes
03/29/2005US6872520 Peptide for use in the detection of viral infection and diseases
03/29/2005US6872406 The fusogenic protein is associated with a phospholipid membrane, such as a liposome.
03/29/2005US6872398 Conjugate vaccine against gram-negative bacterial infections
03/29/2005US6872395 Viruses comprising mutant ion channel protein
03/29/2005US6872394 Non-toxic immune stimulating enterotoxin compositions
03/29/2005US6872393 Polyalkylene oxide-modified single chain polypeptides
03/29/2005US6872391 Nucleotide sequences coding polypeptide for use in the treatment of eating disorders
03/29/2005US6872317 Comprises natural/regenerated fiber; waste treatment; pollution control
03/29/2005CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate
03/29/2005CA2323506C Mammalian blood loss-induced gene, kd312
03/29/2005CA2195745C Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
03/29/2005CA2180950C Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
03/29/2005CA2108699C Method of purification of amylase, purified amylase so obtained and uses of purified amylase
03/29/2005CA2072023C Polypeptides involved in the biosynthesis of cobalamines and/or cobamides, dna sequences coding for theses polypeptides, and their preparation and use
03/29/2005CA2065346C Tumor necrosis factor-.alpha. and-.beta. receptors
03/29/2005CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate
03/26/2005CA2441695A1 Regulation of matrix metalloproteinases by psp94 family members
03/24/2005WO2005026733A1 Method and device for detecting feline immunodeficiency virus
03/24/2005WO2005026718A1 Stem cell libraries
03/24/2005WO2005026392A2 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes
03/24/2005WO2005026388A2 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
03/24/2005WO2005026370A2 Multi-antigen vectors for melanoma
03/24/2005WO2005026362A2 Lymphatic and blood endothelial cell genes
03/24/2005WO2005026361A1 Soluble ectodomain fragments of met and uses thereof
03/24/2005WO2005026360A1 Cellular model of tauopathies for lead identification and drug discovery